Celldex Therapeutics Earnings Surprises image   This CLDX earnings surprises page last updated 3/11/2024
Celldex Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 -0.74 -0.83 -0.09 (+12%)
Q3 2023 -0.68 -0.81 -0.13 (+19%)
Q2 2023 -0.67 -0.65 +0.02 (-3%)
Q1 2023 -0.63 -0.62 +0.01 (-2%)
Q4 2022 -0.59 -0.56 +0.03 (-5%)
Q2 2022 -0.51 -0.77 -0.26 (+51%)
Q1 2022 -0.45 -0.49 -0.04 (+9%)
Q1 2021 -0.38 -0.42 -0.04 (+11%)
Q2 2020 -0.58 -0.50 +0.08 (-14%)
Q4 2019 -0.90 -0.64 +0.26 (-29%)
Q3 2019 -0.84 -0.75 +0.09 (-11%)
Q2 2019 -1.17 -0.84 +0.33 (-28%)
Q1 2019 -1.14 -1.40 -0.26 (+23%)
Q4 2018 -1.20 -0.81 +0.39 (-32%)
Q3 2018 -1.80 -0.60 +1.20 (-67%)
Q2 2018 -2.10 -1.65 +0.45 (-21%)
Q3 2017 -4.05 -2.10 +1.95 (-48%)
Q2 2017 -4.20 -3.45 +0.75 (-18%)
Q1 2017 -4.35 -4.20 +0.15 (-3%)
Q4 2016 -4.80 -4.50 +0.30 (-6%)
Q3 2016 -4.95 -4.35 +0.60 (-12%)
Q2 2016 -5.10 -4.80 +0.30 (-6%)
Q4 2015 -5.25 -4.95 +0.30 (-6%)
Q3 2015 -5.25 -4.80 +0.45 (-9%)
Q2 2015 -5.10 -4.95 +0.15 (-3%)
Q1 2015 -5.40 -4.95 +0.45 (-8%)
Q4 2014 -5.25 -5.40 -0.15 (+3%)
Q3 2014 -4.95 -4.65 +0.30 (-6%)
Q1 2014 -3.90 -4.95 -1.05 (+27%)
Q4 2013 -4.20 -4.05 +0.15 (-4%)
Q3 2013 -3.60 -4.35 -0.75 (+21%)
Q1 2013 -3.30 -3.45 -0.15 (+5%)
Q4 2012 -3.75 -4.05 -0.30 (+8%)
Q3 2012 -3.60 -3.75 -0.15 (+4%)
Q2 2012 -3.75 -3.45 +0.30 (-8%)
Celldex Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 840000 4.13M +3.29M (-100%)
Q3 2023 580000 1.52M +937000 (-100%)
Q2 2023 530000 268000 -0.26M (-49%)
Q1 2023 410000 967000 +557000 (+136%)
Q4 2022 260000 1.61M +1.35M (-100%)
Q2 2022 400000 163000 -0.24M (-59%)
Q1 2022 560000 174000 -0.39M (-69%)
Q1 2021 685000 685000 NA (0%)
Q2 2020 800000 236000 -0.56M (-70%)
Q4 2019 810000 887000 +77000 (+10%)
Q3 2019 1.26M 546000 -0.71M (+43333233%)
Q2 2019 1.26M 715000 -0.55M (+56745932%)
Q1 2019 1.23M 1.43M +195000 (+16%)
Q4 2018 1.46M 1.76M +304000 (+21%)
Q3 2018 2.19M 941000 -1.25M (+42967937%)
Q2 2018 2.30M 2.76M +463000 (+20%)
Q3 2017 1.09M 3.92M +2.83M (+260%)
Q2 2017 910000 3.83M +2.92M (-100%)
Q1 2017 920000 1.53M +614000 (-100%)
Q4 2016 810000 1.87M +1.06M (-100%)
Q3 2016 850000 2.22M +1.37M (-100%)
Q2 2016 850000 1.39M +539000 (-100%)
Q4 2015 700000 1.79M +1.09M (-100%)
Q3 2015 780000 1.03M +246000 (-100%)
Q2 2015 450000 2.18M +1.73M (-100%)
Q1 2015 450000 500000 +50000 (+11%)
Q4 2014 390000 320000 -70000 (-18%)
Q3 2014 360000 1.10M +740000 (-100%)
Q1 2014 250000 416000 +166000 (+66%)
Q4 2013 270000 620000 +350000 (+130%)
Q3 2013 90000 980000 +890000 (+989%)
Q1 2013 2.42M 2.41M -10000 (-0%)
Q4 2012 2.45M 3.65M +1.20M (+49%)
Q3 2012 2.07M 3.10M +1.03M (+50%)
Q2 2012 2.17M 2.01M -0.16M (-7%)
Quotes delayed 20 minutes

Email EnvelopeFree CLDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 3/11/2024 7:00 AM
Overseas Shipholding Gr (OSG): 3/11/2024 7:30 AM
Genie Energy (GNE): 3/11/2024 7:30 AM
Curis (CRIS): 3/11/2024 8:00 AM
Ocular Therapeutix (OCUL): 3/11/2024 After close
Ranpak Hldgs (PACK): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Assertio Holdings (ASRT): 3/11/2024 After close
Amylyx Pharma (AMLX): 3/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

Cue Biopharma (CUE): 3/9/2024 After close
Ovid Therapeutics (OVID): 3/8/2024 8:00 AM
America's Car-Mart (CRMT): 3/8/2024 8:00 AM
Sigmatron International (SGMA): 3/8/2024 8:00 AM
XOMA (XOMA): 3/8/2024 7:30 AM
Dixie Gr (DXYN): 3/8/2024 7:00 AM
Genesco (GCO): 3/8/2024 6:50 AM
Nine Energy Service (NINE): 3/7/2024 5:00 PM
Ring Energy (REI): 3/7/2024 After close
Team (TISI): 3/7/2024 After close

More from the Earnings History archive
Celldex Therapeutics (CLDX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CLNN Historical Earnings
CLOV Historical Earnings
CLPT Historical Earnings
CLRB Historical Earnings
CLSD Historical Earnings
CLSN Historical Earnings
CLVS Historical Earnings
CLXT Historical Earnings
CMAX Historical Earnings
CMD Historical Earnings
On this page we presented the CLDX earnings surprises information for Celldex Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on CLDX (or any other given stock) can benefit from researching all of the Celldex Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Celldex Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about CLDX's next earnings report. In your continued research on Celldex Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for CLDX. Thanks for visiting, and the next time you need to research CLDX earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Stronghold Digital Mining Historical PE Ratio, FIF Historical Stock Prices, ETFs Holding ALNY.

 

Celldex Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.